AU2001271026A1 - Remedies for bone diseases - Google Patents

Remedies for bone diseases

Info

Publication number
AU2001271026A1
AU2001271026A1 AU2001271026A AU7102601A AU2001271026A1 AU 2001271026 A1 AU2001271026 A1 AU 2001271026A1 AU 2001271026 A AU2001271026 A AU 2001271026A AU 7102601 A AU7102601 A AU 7102601A AU 2001271026 A1 AU2001271026 A1 AU 2001271026A1
Authority
AU
Australia
Prior art keywords
remedies
bone diseases
bone
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001271026A
Inventor
Jane E. Aubin
Akira Igarashi
Yoshio Koide
Norihiko Maeda
Shoichi Takano
Yuji Yoshiko
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BML Inc
Original Assignee
BML Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BML Inc filed Critical BML Inc
Publication of AU2001271026A1 publication Critical patent/AU2001271026A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001271026A 2000-07-11 2001-07-10 Remedies for bone diseases Abandoned AU2001271026A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000209926 2000-07-11
JP2000-209926 2000-07-11
PCT/JP2001/005962 WO2002004013A1 (en) 2000-07-11 2001-07-10 Remedies for bone diseases

Publications (1)

Publication Number Publication Date
AU2001271026A1 true AU2001271026A1 (en) 2002-01-21

Family

ID=18706269

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001271026A Abandoned AU2001271026A1 (en) 2000-07-11 2001-07-10 Remedies for bone diseases

Country Status (6)

Country Link
US (1) US20040254102A1 (en)
EP (1) EP1304117A4 (en)
JP (1) JP4955186B2 (en)
AU (1) AU2001271026A1 (en)
CA (1) CA2415709A1 (en)
WO (1) WO2002004013A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003288906C1 (en) * 2002-09-20 2010-12-09 Yale University Riboswitches, methods for their use, and compositions for use with riboswitches.
WO2013008681A1 (en) 2011-07-09 2013-01-17 国立大学法人東北大学 Pharmaceutical composition for preventing or treating fibrosis
CN114096526A (en) 2019-07-02 2022-02-25 诺华股份有限公司 Prostate Specific Membrane Antigen (PSMA) ligands and uses thereof
KR20220044496A (en) 2019-07-02 2022-04-08 어드밴스드 액셀러레이터 어플리케이션즈 (이태리) 에스알엘 Prostate specific membrane antigen (PSMA) ligands and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07188051A (en) * 1993-11-16 1995-07-25 Pola Chem Ind Inc Bone metabolism-controlling substance and treating agent for metabolic bone disease
US5837498A (en) * 1994-03-08 1998-11-17 Human Genome Scienes, Inc. Corpuscles of stannius protein, stanniocalcin
US5994103A (en) * 1995-06-02 1999-11-30 Human Genome Science, Inc. Human stanniocalcin-alpha
US6008322A (en) * 1996-04-02 1999-12-28 Zymogenetics, Inc. Stanniocalcin-2
US6171822B1 (en) * 1996-04-02 2001-01-09 Zymogenetics, Inc. Stanniocalcin-2
JP2000229880A (en) * 1999-02-10 2000-08-22 Snow Brand Milk Prod Co Ltd Accelerating agent for osteoplasty
CA2387685A1 (en) * 1999-10-27 2001-05-03 Human Genome Sciences, Inc. Stanniocalcin proteins and nucleic acids and methods based thereon

Also Published As

Publication number Publication date
EP1304117A1 (en) 2003-04-23
EP1304117A4 (en) 2005-04-27
WO2002004013A1 (en) 2002-01-17
CA2415709A1 (en) 2003-01-10
JP4955186B2 (en) 2012-06-20
US20040254102A1 (en) 2004-12-16

Similar Documents

Publication Publication Date Title
AU2001246876A1 (en) Remedies
AU2001246877A1 (en) Remedies
AU2001241963A1 (en) Improved medical procedure
AU2001269529A1 (en) Medicine comprising dicyanopyridine derivative
AUPQ893200A0 (en) Medical residue treatment
AU2001253342A1 (en) Surgical implant system
AU2001286221A1 (en) Remedies for ischemic diseases
AU2001254786A1 (en) Medical implant
AU2001279540A1 (en) Dental splint
AU2001259702A1 (en) Tissue regrafting
AU2001252599A1 (en) Remedies for cancer
AU2001233208A1 (en) Human sulfatases
AU2000279614A1 (en) Remedies for endothelin-induced diseases
AU2001277711A1 (en) Remedies for cisplatin-tolerant cancer
AU2001256201A1 (en) Device for administering implants
AU2000265525A1 (en) Medicament for treating intestinal diseases
AU2001241162A1 (en) Remedies for allergic diseases
AU2002315848A1 (en) Remedies for eosinophilic diseases
AU2001236006A1 (en) Preventives/remedies for kidney diseases
IL159478A0 (en) Remedies for eosinophilic diseases
AU2001234270A1 (en) Bandage for orthopaedic use
AU2001247841A1 (en) Medical procedure
AU2001271026A1 (en) Remedies for bone diseases
HUP0004670A2 (en) Surgical device-set for spine-fixture
AU2001228863A1 (en) Remedies for ophthalmic diseases